Virtus Fund Advisers’s Standard BioTools LAB Stock Holding History

Virtus Fund Advisers’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-48,031	Closed	-$1.16M	–	851
2015 Q2	$1.16M	Sell	48,031 -670	-1%	-$21.1K	0.01%	353
2015 Q1	$2.05M	Sell	48,701 -5,057	-9%	-$200K	0.02%	318
2014 Q4	$1.81M	Buy	53,758 +274	+0.5%	+$7.76K	0.01%	339
2014 Q3	$1.31M	Sell	53,484 -2,002	-4%	-$56.3K	0.01%	380
2014 Q2	$1.63M	Buy	+55,486	New	+$1.78M	0.01%	390

Other funds holding LAB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Virtus Fund Advisers's LAB Position: Q3 2015 in Review

Virtus Fund Advisers sold out of Standard BioTools (LAB) in Q3 2015, closing a stake of 48,031 shares — an estimated $1.16M sold.

Virtus Fund Advisers first reported a position in LAB in Q2 2014 and held it in 5 quarters. The position peaked at $2.05M in Q1 2015. 109 funds tracked by Wall St. Rank hold LAB as of Q3 2015.

Virtus Fund Advisers reported no remaining Standard BioTools position as of Q3 2015 after selling out during the quarter.
Virtus Fund Advisers sold 48,031 Standard BioTools shares in Q3 2015, an estimated $1.16M.
Virtus Fund Advisers first reported a position in Standard BioTools in Q2 2014 and held it in 5 quarters.
Virtus Fund Advisers's Standard BioTools position peaked at $2.05M in Q1 2015.
109 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2015.

Based on Virtus Fund Advisers's 13F filing for Q3 2015, filed 10 Nov 2015.